We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEBK icon
6676
Peoples Bancorp of North Carolina
PEBK
$229M
$133K ﹤0.01%
4,270
+553
+15% +$15.8K
DIT icon
6677
AMCON Distributing
DIT
$67.2M
$133K ﹤0.01%
1,559
+291
+23% +$25.9K
LGOV icon
6678
First Trust Long Duration Opportunities ETF
LGOV
$622M
$133K ﹤0.01%
+6,388
New +$137K
FDVV icon
6679
Fidelity High Dividend ETF
FDVV
$10.4B
$133K ﹤0.01%
2,663
+163
+7% +$8.35K
PPI
6680
AXS Astoria Inflation Sensitive ETF
PPI
$159M
$133K ﹤0.01%
9,177
+6,767
+281% +$104K
SLS icon
6681
SELLAS Life Sciences
SLS
$2.36B
$133K ﹤0.01%
+127,821
New +$146K
GRF
6682
Eagle Capital Growth Fund
GRF
$41.5M
$133K ﹤0.01%
13,625
+11,853
+669% +$118K
GNT
6683
GAMCO Natural Resources, Gold & Income Trust
GNT
$144M
$133K ﹤0.01%
25,109
-3,574
-12% -$20.7K
PIM
6684
Franklin Master Intermediate Income Trust
PIM
$151M
$132K ﹤0.01%
40,588
+7,700
+23% +$25.4K
APO.PRA
6685
DELISTED
Apollo Global Management Series A
APO.PRA
$132K ﹤0.01%
1,522
+1,309
+615% +$110K
SBC
6686
SBC Medical Group
SBC
$314M
$132K ﹤0.01%
23,739
+20,529
+640% +$140K
EMF
6687
Templeton Emerging Markets Fund
EMF
$326M
$132K ﹤0.01%
11,041
+137
+1% +$1.77K
CTSO icon
6688
Cytosorbents Corp
CTSO
$22.6M
$132K ﹤0.01%
144,925
+142,354
+5,537% +$140K
IVDA icon
6689
Iveda Solutions
IVDA
$3.54M
$131K ﹤0.01%
26,498
+21,296
+409% +$43.9K
NSLR
6690
Neostellar Capital Corp
NSLR
$254M
$131K ﹤0.01%
22,250
+9,579
+76% +$49K
BCG
6691
Binah Capital Group
BCG
$22.7M
$131K ﹤0.01%
+44,479
New +$116K
MKOR icon
6692
Matthews Korea Active ETF
MKOR
$132M
$131K ﹤0.01%
+6,283
New +$149K
OBDE
6693
DELISTED
Blue Owl Capital Corporation III
OBDE
$131K ﹤0.01%
9,050
+3,917
+76% +$57.6K
QMMM
6694
QMMM Holdings
QMMM
$130K ﹤0.01%
+101,813
New +$525K
CRDF icon
6695
PUT
Cardiff Oncology
CRDF
$77.2M
$130K ﹤0.01%
+30,000
New +$93.8K
MSD
6696
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$130K ﹤0.01%
16,856
-5,438
-24% -$41.9K
AVMA icon
6697
Avantis Moderate Allocation ETF
AVMA
$81.3M
$130K ﹤0.01%
2,232
+2,185
+4,649% +$131K
BRZU icon
6698
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$97.7M
$130K ﹤0.01%
+3,133
New +$181K
INSI
6699
DELISTED
Insight Select Income Fund
INSI
$130K ﹤0.01%
7,477
+1,106
+17% +$19.2K
EVH icon
6700
PUT
Evolent Health
EVH
$447M
$129K ﹤0.01%
11,500
-1,000
-8% -$17.6K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.